- Proteon Therapeutics (NASDAQ:PRTO) initiated with Buy rating and $18 (91% upside) price target by H.C. Wainwright.
- Oncomed Pharmaceuticals (NASDAQ:OMED) initiated with Buy rating and $20 (62% upside) price target by H.C. Wainwright.
- Gilead Sciences (NASDAQ:GILD) initiated with Buy rating by Berenberg Bank.
- CASI Pharmaceuticals (NASDAQ:CASI) initiated with Buy rating and $4 (254% upside) price target by Maxim Group.
- Novartis (NYSE:NVS) initiated with Buy rating and $95 (16% upside) price target by Chardan Capital.
- Invuity (NASDAQ:IVTY) initiated with Buy rating and $18 (31% upside) price target by Lake Street Capital.
- Cerner (NASDAQ:CERN) initiated with Buy rating and $67 (6% upside) price target by Bank of America.
- Healthcare Services Group (NASDAQ:HCSG) initiated with Outperform rating and $46 (18% upside) price target by Baird.